T-Cypher Bio
4 known investors
T-Cypher Bio develops drugs with curative potential, focusing on antibody development, T cell biology, and TCR discovery. The company applies immunology and AI-driven approaches in the biotech sector.
Investors · 4
In the news
Frequently asked questions
- What does T-Cypher Bio do?
- T-Cypher Bio develops drugs with curative potential, focusing on antibody development, T cell biology, and TCR discovery. The company applies immunology and AI-driven approaches in the biotech sector.
- Who are T-Cypher Bio's investors?
- T-Cypher Bio's investors include Future Planet Capital, LifeArc Ventures, Oxford Science Enterprises, Perivoli Innovations.